Jeong Heo

23PUBLICATIONS
115CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsHaematological tumoursNeural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 26, 2026
Discordant Antitumor Efficacy with Compromised Survival in High-Risk Unresectable Hepatocellular Carcinoma.

|Jun 09, 2026
A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma.

|May 08, 2026
Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C.

|Apr 13, 2026
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.

Stuart C Gordon, Alejandra Villamil, Ira M Jacobson

|Feb 26, 2026
Therapeutic Strategies for Hepatocellular Carcinoma: Current Advances and Future Perspectives.

Palaniyandi Muthukutty, Jeong Heo, So Young Yoo

|Nov 07, 2025
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.

Grace Lai-Hung Wong, Man-Fung Yuen, Bingliang Lin

Pageof 4

Frequent Collaborators

5 joint publications

Ki Tae Yoon

5 joint publications

Hyun Young Woo

4 joint publications

Young Mi Hong

4 joint publications

So Young Yoo